Recombinant human erythropoietin (Shanghai Huaxin)
重组人红细胞生成素（上海华新）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant human erythropoietin (Shanghai Huaxin)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesShanghai Huaxin Biotechnology Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesShanghai Huaxin Biotechnology Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksN/A